DK0903150T3 - Regulering af immunoglobulinproduktion med interleukin-9 - Google Patents

Regulering af immunoglobulinproduktion med interleukin-9

Info

Publication number: DK0903150T3
Authority: DK; Denmark
Prior art keywords: interleukin; production; regulation; immunoglobulin production; ige
Prior art date: 1990-10-05

Application number

DK98200841T

Other languages

English (en)

Inventor

Bernard Dugas

Catherine Druez

Pierre Braquet

Catherine Uyttenhove

Snick Charles Van

Jean-Michel Mencia-Huerta

Jean-Christophe Renauld

Original Assignee

Ludwig Inst Cancer Res

Sod Conseils Rech Applic

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-05

Filing date

1991-10-01

Publication date

2003-07-21

1991-10-01 Application filed by Ludwig Inst Cancer Res, Sod Conseils Rech Applic filed Critical Ludwig Inst Cancer Res

2003-07-21 Application granted granted Critical

2003-07-21 Publication of DK0903150T3 publication Critical patent/DK0903150T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/247—IL-4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2033—IL-5
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Pulmonology (AREA)
Transplantation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Transceivers (AREA)
Mobile Radio Communication Systems (AREA)

DK98200841T 1990-10-05 1991-10-01 Regulering af immunoglobulinproduktion med interleukin-9 DK0903150T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/593,238 US5132109A (en)	1990-10-05	1990-10-05	Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof

Publications (1)

Publication Number	Publication Date
DK0903150T3 true DK0903150T3 (da)	2003-07-21

Family

ID=24373963

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK91918691T DK0553198T3 (da)	1990-10-05	1991-10-01	Regulering af immunoglobulinproduktionen med interleukin-9
DK98200841T DK0903150T3 (da)	1990-10-05	1991-10-01	Regulering af immunoglobulinproduktion med interleukin-9

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK91918691T DK0553198T3 (da)	1990-10-05	1991-10-01	Regulering af immunoglobulinproduktionen med interleukin-9

Country Status (11)

Country	Link
US (1)	US5132109A (da)
EP (2)	EP0553198B1 (da)
JP (2)	JP3205754B2 (da)
AT (2)	ATE234632T1 (da)
AU (2)	AU646509B2 (da)
CA (1)	CA2093434C (da)
DE (2)	DE69131450T2 (da)
DK (2)	DK0553198T3 (da)
ES (2)	ES2194273T3 (da)
GR (1)	GR3031518T3 (da)
WO (1)	WO1992005698A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0643719T3 (da) *	1992-03-09	1999-06-28	Ludwig Inst Cancer Res	Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
DE4322330A1 (de)	1992-08-31	1994-03-03	Behringwerke Ag	Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen
US5601815A (en) *	1992-08-21	1997-02-11	Schering Corp	IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
US6911887B1 (en)	1994-09-12	2005-06-28	Matsushita Electric Industrial Co., Ltd.	Inductor and method for producing the same
AU2007202406B2 (en) *	1995-08-24	2010-08-12	Ligand Pharmaceuticals Inc.	Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
US5908839A (en) *	1995-08-24	1999-06-01	Magainin Pharmaceuticals, Inc.	Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
EP0846173B1 (en) *	1995-08-24	2005-10-19	Genaera Corporation	Use of an anti-interleukin-9 antibody for the preparation of a medicament for the treatment of asthma
US5830454A (en) *	1996-08-30	1998-11-03	Ludwig Institute For Cancer Research	Method for treating cell mediated autoimmune disorders using interleukin-9
EP1471144B1 (en) *	1996-12-02	2010-06-23	Genaera Corporation	Biological variability of asthma associated factor AAF2 (IL-9 receptor) useful in treating and diagnosing atopic allergies including asthma and related disorders
WO1998024904A2 (en) *	1996-12-02	1998-06-11	Magainin Pharmaceuticals Inc.	Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
WO2002100432A1 (en) *	2001-06-08	2002-12-19	Genaera Corporation	Methods for the modulation of il-13
JP4270974B2 (ja)	2003-08-04	2009-06-03	本田技研工業株式会社	車両における燃料タンクの配置構造
US20100219541A1 (en)	2007-09-28	2010-09-02	Konica Minolta Opto, Inc.	Method for manufacturing optical device
JP5429159B2 (ja)	2008-03-19	2014-02-26	コニカミノルタ株式会社	ウエハレンズの製造方法
EP2255941A4 (en)	2008-03-19	2014-05-28	Konica Minolta Opto Inc	METHOD FOR MANUFACTURING THIN LENS
CN102472839B (zh)	2010-04-27	2015-05-13	柯尼卡美能达精密光学株式会社	摄像用透镜、晶片透镜、晶片透镜层叠体、摄像用透镜的制造方法、摄像用透镜的中间物、摄像用透镜的中间物的制造方法
US9828087B2 (en) *	2016-01-27	2017-11-28	Honeywell International Inc.	Systems and methods for ground effect ceiling limit display

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US511951A (en) *		1894-01-02		Chusetts
US5017691A (en) *	1986-07-03	1991-05-21	Schering Corporation	Mammalian interleukin-4
US5041381A (en) *	1986-07-03	1991-08-20	Schering Corporation	Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
US5013824A (en) *	1985-11-19	1991-05-07	Schering Corporation	Human interleukin-4 peptides and conjugates thereof
US4946945A (en) *	1987-06-23	1990-08-07	Allergy Immuno Technologies, Inc.	Immunotherapy agents for treatment of IgE mediated allergies
US5208218A (en) *	1988-09-19	1993-05-04	Ludwig Institute For Cancer Research	T cell growth factor glycoproteins
US5580753A (en) *	1989-05-23	1996-12-03	Ludwig Institute For Cancer Research	DNA encoding the human cytokine, interleukin-9
AU7552691A (en) *	1990-03-23	1991-10-21	GSF-Institut Fur Experimentalle Hamatologie	Method for enhanced growth and proliferation of mast cells

1990
- 1990-10-05 US US07/593,238 patent/US5132109A/en not_active Expired - Lifetime
1991
- 1991-10-01 JP JP51793791A patent/JP3205754B2/ja not_active Expired - Fee Related
- 1991-10-01 DE DE69131450T patent/DE69131450T2/de not_active Expired - Lifetime
- 1991-10-01 EP EP91918691A patent/EP0553198B1/en not_active Expired - Lifetime
- 1991-10-01 DE DE69133225T patent/DE69133225T2/de not_active Expired - Lifetime
- 1991-10-01 ES ES98200841T patent/ES2194273T3/es not_active Expired - Lifetime
- 1991-10-01 AT AT98200841T patent/ATE234632T1/de not_active IP Right Cessation
- 1991-10-01 EP EP98200841A patent/EP0903150B1/en not_active Expired - Lifetime
- 1991-10-01 ES ES91918691T patent/ES2136065T3/es not_active Expired - Lifetime
- 1991-10-01 AT AT91918691T patent/ATE182079T1/de not_active IP Right Cessation
- 1991-10-01 WO PCT/US1991/007208 patent/WO1992005698A1/en not_active Ceased
- 1991-10-01 AU AU87607/91A patent/AU646509B2/en not_active Expired
- 1991-10-01 CA CA002093434A patent/CA2093434C/en not_active Expired - Lifetime
- 1991-10-01 DK DK91918691T patent/DK0553198T3/da active
- 1991-10-01 DK DK98200841T patent/DK0903150T3/da active
1993
- 1993-12-14 AU AU52434/93A patent/AU656493B2/en not_active Expired
1999
- 1999-10-13 GR GR990402614T patent/GR3031518T3/el unknown
2001
- 2001-03-21 JP JP2001079636A patent/JP2001253835A/ja active Pending

Also Published As

Publication number	Publication date
ES2136065T3 (es)	1999-11-16
AU646509B2 (en)	1994-02-24
ES2194273T3 (es)	2003-11-16
EP0903150A1 (en)	1999-03-24
DE69133225T2 (de)	2004-02-19
JP2001253835A (ja)	2001-09-18
ATE182079T1 (de)	1999-07-15
DE69131450D1 (de)	1999-08-19
GR3031518T3 (en)	2000-01-31
EP0553198A4 (en)	1994-08-17
DK0553198T3 (da)	1999-12-27
CA2093434C (en)	1999-08-10
US5132109A (en)	1992-07-21
CA2093434A1 (en)	1992-04-06
JP3205754B2 (ja)	2001-09-04
AU8760791A (en)	1992-04-28
AU5243493A (en)	1994-02-17
ATE234632T1 (de)	2003-04-15
JPH06502404A (ja)	1994-03-17
WO1992005698A1 (en)	1992-04-16
EP0553198A1 (en)	1993-08-04
DE69133225D1 (de)	2003-04-24
AU656493B2 (en)	1995-02-02
EP0903150B1 (en)	2003-03-19
EP0553198B1 (en)	1999-07-14
DE69131450T2 (de)	2000-03-30

Publication	Publication Date	Title
DK0903150T3 (da)	2003-07-21	Regulering af immunoglobulinproduktion med interleukin-9
DK0497706T3 (da)	1997-04-21	Termoformbar komposition, fremgangsmåde til fremstilling heraf samt anvendelse heraf med henblik på at opnå termoformede emner
PL313260A1 (en)	1996-06-24	Monoclonal antibodies having properties making them able to cause apoptosis
SE9102074D0 (sv)	1991-07-03	Tomour antigen specific antibody
DK183590A (da)	1990-09-27	Fremgangsmaade til reduktion af immunoglobulin e-responser
FI935408A0 (fi)	1993-12-02	Spaoraemnesrikt tillsatsmedel, foerfarande foer framstaellning daerav, preparat innehaollande detta och dess anvaendning
FI850778A7 (fi)	1985-09-03	Menetelmä NO x-pitoisuuden alentamiseksi pyörrekerrospolttolaitteissa.
BG41993A3 (en)	1987-09-15	Means and method for increase in cold resistance of plant cultures
NO172596C (no)	1993-08-11	Apolipoprotein b-spesifikke monoklonale antistoffer produsert av to nye hybridomer, anvendelse av disse og diagnostiske systemer inneholdende disse
NL940019I2 (nl)	1997-07-01	Remming van het infecterende karakter in vitro en het cytopatische effect van HTV-III/LAV door 2',3-didesoxycytidine.
DK154188A (da)	1988-09-26	Kraftanlaeg med forbraending i fluidiseret leje
ES2164211T3 (es)	2002-02-16	Procedimiento mejorado para la fabricacion de sal de 5-(alcoximetil)piridin-2,3-dicarboxilato.
DK0479884T3 (da)	1995-06-06	Kraftværk med fluid-bed forbrændingsreaktor
DE3862547D1 (de)	1991-05-29	Vorrichtung zur anaeroben behandlung von biomasse.
DK159141C (da)	1991-03-18	Fremgangsmaade til fremstilling af kautsjukmkaatter med mindst et yderligere lag kautsjuk i randzonen
DK575183D0 (da)	1983-12-14	Fremgangsmaade og anlaeg til stroemforsyning af vekselstroemsnet med en dieselmotor
DK447784D0 (da)	1984-09-19	Immuninterferon
ATE148163T1 (de)	1997-02-15	Monoklonale antikörper gegen leptosphaeria
DK511479A (da)	1980-06-16	Regulering for koeremotor foedet af stroemretter i det svage feltomraade
GB8811342D0 (en)	1988-06-15	Expression of antibody heavy & light chain variable domains as active hetero-dimer in myeloma cells
SU1692146A1 (ru)	2000-03-20	Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o
DE69118827D1 (de)	1996-05-23	Antikörper gegen Hamsterimmunglobulinen
FI804079L (fi)	1982-07-01	Avdunstande luftfuktare foersedd med flaekt i
IT7711524U1 (it)	1978-08-14	Metro molti usi che permette la possibilita' di confrontare parametri necessari e utili per la verifica e il controllo della crescita e lo sviluppo dei bambini
ATE26411T1 (de)	1987-04-15	Verfahren fuer die reduzierung des so2- und/oder nox-gehaltes in rauchgas.